Journey Medical Corporation (DERM)
Last updated: 2026-10-20 12:08:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
Journey Medical Corporation (DERM) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $5.19, with a market capitalization of $140.13M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4.31 to $9.56. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$140.13M | |
$5.19 | |
$38.75 | |
$1.02 | |
$5.17 | |
1.00 | |
193.53K | |
-- | |
$9.56 | |
$4.31 | |
-- | |
-- |
Journey Medical Corporation (DERM) Pre-Market Stock Price
Journey Medical Corporation (DERM) is trading at $5.19 in pre-market trading as of 2026-10-20 10:28:00, up 0.29% ($0.01) from the previous close of $5.17
Pre-market trading shows how investors are pricing DERM before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Journey Medical Corporation (DERM) 7-Day Stock Price Change
Over the past seven days, Journey Medical Corporation (DERM) moved from $6.31 to $5.19, representing a decline of 17.83% ($1.13).
The stock traded between $4.78 and $6.46 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 213.66 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
DERM 52-Week Price Position
Position in Range: 16.7%
DERM is currently trading at $5.19, placing it 16.7% of the way from its 52-week low of $4.31 to its 52-week high of $9.56. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Journey Medical Corporation (DERM)?
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
Journey Medical Corporation Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 58 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Journey Medical Corporation (DERM) Stock on MEXC
Eligible investors can buy real shares of Journey Medical Corporation (DERM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Journey Medical Corporation (DERM) stock price today?
2.Is DERM stock going up or down today?
3.What is DERM pre-market price?
4.What is DERM after-hours price?
5.Is DERM stock trading now?
6.Where does DERM sit relative to its 52-week high and low?
7.What sector is Journey Medical Corporation in?
8.What is Journey Medical Corporation's market capitalization and where is it listed?
9.How is DERM valued in terms of P/E ratio and EPS?
10.Does Journey Medical Corporation pay a dividend?
Explore More US Stocks
Search Stocks
DERM Stock Calculator
Estimate the value between DERM shares and USD.
DERM Shares to USD
1.00 DERM shares = 5.185 USD
Calculations are estimates based on the latest available price and are for reference only.


